Blood Transfusion Rate in Patients Undergoing Benign Prostatic Hyperplasia

Abstract

Background and Objective: Benign Prostatic Hyperplasia (BPH) is defined as the enlargement of the prostate gland in the presence of urinary symptoms without any evidence of malignancy. For patients who have failed medical treatment as the first line of therapy, surgical intervention will be administered as the treatment. Hemorrhage is one of the most dreadful and serious complications of prostate surgery. Bleeding can often be significant and lead to increased morbidity and occasionally mortality. If it persists, it may necessitate blood transfusion and can lead to clot retention in the postoperative period. Materials and Methods: This study was conducted on 87 patients with benign prostatic hyperplasia, who underwent surgical intervention (open prostatectomy and transurethral resection of the prostate) for a year. The volume of packed cell transfusion in these patients was determined and compared based on the surgical method and other variables. The collected data were analyzed in SPSS (version 24). Results: The mean age of the patients was 71.3±9.56 years, and 26.4% of the subjects were under 65 years old. Among the cases, 93.1% of patients underwent transurethral resection of prostate surgery and 7.7% received a blood transfusion. It was found that 41.4%, 12.6%, 10.3%, 3.4%, and 1.1% of the participants had high blood pressure, diabetes, ischemic heart disease, hypothyroidism, and dyslipidemia, respectively. The means of pre- and post-operative hemoglobin were obtained at 13.16±1.83 and 12.33±2.17, respectively, and those of pre- and post-operative hematocrit were estimated at 38.64±4.84 and 36.72±5.72, respectively. Conclusion: Transurethral resection of prostate surgery had a lower rate of blood transfusion, compared to open surgery. The age of the patients and a history of underlying diseases were not significantly related to blood transfusion percentage in these patients. However, the frequency of blood transfusion was higher in patients with hypertension than in those with other diseases; nevertheless, it was not significant.